|
Comparison of the Effects of Estradiol Cream and Vaginal Misoprostol Suppository on Cervical Preparation
|
Jila Agah1    , Roya Baghani 2, Mohamad hasan Rakhshani3 |
1- Associate Professorand gynecologist, member in faculty of medical sciences, Department of Obstetrics and Gynecology, Sabzevar University of Medical Sciences, Sabzevar, Iran.
2- Master of midwifery, member in faculty of medical sciences(corresponding Auther) School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, Iran , ry.baghany@gmail.com
3- Assistant Professor sabzevar university. , member in faculty of medical sciences . Sabzevar University of Medical Sciences, Sabzevar, Iran. |
|
|
Abstract: (1415 Views) |
Background and Aim :One of the methods of preparing the cervix for induction of labor is use of drugs. Use of prostaglandins and estradiol is one of these methods. The aim of this study was to compare the effects of estradiol and misoprostol on cervical preparation.
Materials and Methods: This study included 100 pregnant women with Bishop score of less than four who had referred for normal delivery. The participants assigned to groups of misoprostol suppository and estradiol cream by random method. The women were examined every two hours and cervical Bishop score and labor progress were assessed. If uterine contractions were not suitable after 6 hours, induction with oxytocin was performed by the conventional method. Finally, two groups were compared in relation to Bishop score, onset of uterine contractions, lengths of labor stages, rate of cesarean section, and maternal and fetal complications by use of SPSS22 software. p<0.05 was considered significant.
Results: After two and four hours, Bishop scores were higher in the estradiol group than those in the misoprostol group (P<0.05). Need for oxytocin in the first and second stages of labor was more in the misoprostol group than in the estradiol group (P=0.001). The duration of the first stage in the misoprostol group was higher compared to that in the estradiol group (P=0.004) and there was no statistically significant difference between the lengths of the second and third stages and the type of delivery. (P > 0.05)
Conclusion: Estradiol cream can be used to prepare the cervix for childbirth. Use of this method, can reduce the duration of the first stage of labor without any complications for mothers and babies. This method can reduce the rate of cesarean section and result in better health of the mothers and babies.
|
|
| Keywords: Prostaglandin, Estradiol, Bishop score, Cervical ripening |
|
|
Full-Text [PDF 1045 kb]
(399 Downloads)
|
Type of Study: Original Research |
Subject:
Midwifery
Received: 2021/04/15 | Accepted: 2021/12/28 | Published: 2023/05/28
|
|
|
|
|
|
|
| References |
1. 1.Agah J, Baghani R, Nazarzadeh M, Borna S. Comparison of effacement curve with dilatation curve for prediction of labor progression. J Obstet Gynaecol Res. 2018;44(1):102-8. Available from :DOI: 10.1111/jog.13478 [ DOI:10.1111/jog.13478] [ PMID] 2. Murthy K, Grobman WA, Lee TA, Holl JL. Trends in induction of labor at early-term gestation. Am. J. Obstet. Gynecol .2011;204(5):435. e1- 6. Available from: DOI: 10.1016/j.ajog.2010.12.023 [ DOI:10.1016/j.ajog.2010.12.023] [ PMID] 3. Chiossi G, Yinglei L, Landon MB, Spong CY, Rouse DJ, Varner MW, et al. Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries. Obstet. Gynecol. 2013;121(3):561-569. Available from: DOI: 10.1097/AOG.0b013e3182822193 [ DOI:10.1097/AOG.0b013e3182822193] [ PMID] [ ] 4. Agah J, Baghany R, Safiabadi-Tali SH. Effects of Continuous vs. Intermittent Method of Entonox on Labor Progress. Zahedan. J. Res. Med. Sci. 2015;17(11): 1-3. Available from :DOI:10.17795/zjrms-2215 [ DOI:10.17795/zjrms-2215] 5. Spong CY, Berghella V, Wenstrom KD, Mercer BM, Saade GR. Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver national institute of child health and human development, society for maternal-fetal medicine, and American college of obstetricians and gynecologists workshop. Obstet Gynecol. 2012;120(5):1181-1193. Available from :DOI: 10.1097/aog.0b013e3182704880 [ DOI:10.1097/AOG.0b013e3182704880] [ PMID] 6. Guinn D A , Davies J K, Jones RO, Sullivan L, Wolf D. Labor induction in women with an unfavorable Bishop score: randomized controlled trial of intrauterine Foley catheter with concurrent oxytocin infusion versus Foley catheter with extra-amniotic saline infusion with concurrent oxytocin infusion. Am J Obstet Gynecol. 2004 Jul;191(1):225-9. DOI: 10.1016/j.ajog.2003.12.039. [ DOI:10.1016/j.ajog.2003.12.039] [ PMID] 7. Moukhah S, Ahmadi F. Preinduction cervical ripening using oral and vaginal isosorbide dinitrate in patients with term pregnancy: Arandomized clinical trial. Adv Biomed Res 2015;17(4):863-870. Available from : DOI: 10.4103/2277-9175.158259 [ DOI:10.4103/2277-9175.158259] [ PMID] [ ] 8. Peregrine E, O'brien P, Omar R, Jauniaux E. Clinical and ultrasound parameters to predict the risk of cesarean delivery after induction of labor. Obstet Gynecol 2006;107(2):227-33. Available from:DOI: 10.1097/01.AOG.0000196508.11431.c0 [ DOI:10.1097/01.AOG.0000196508.11431.c0] [ PMID] 9. Cunningham F.Gary, Leveno J.Kenneth , Bloom L.Steven , Hauth C.John , Rouse J.Dwight , Spong Y.Catherine. Williams Obstetrics.23 th ed. Mc Graw Hill. USA ,2010:520-535 10. .Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and pharmacologic methods of labor induction: a randomized controlled trial. Obstet Gynecol. 2016;128(6):1357. Available from:DOI: 10.1097/AOG.0000000000001778 [ DOI:10.1097/AOG.0000000000001778] [ PMID] [ ] 11. Stitely M L , Browning J, Fowler M, Gendron R T, Gherman R B. Outpatient cervical ripening with intravaginal misoprostol. Obstet Gynecol. 2000 Nov;96(5 Pt 1):684-8. Available from: DOI: 10.1016/s0029-7844(00)01034-6. [ DOI:10.1016/S0029-7844(00)01034-6] [ PMID] 12. Chen W, Xue J, Peprah M, Wen S, Walker M, Gao Y, et al. A systematic review and network meta‐analysis comparing the use of Foley catheters, misoprostol, and dinoprostone for cervical ripening in the induction of labour. BJOG:. 2016;123(3):346-54. Available from: DOI: 10.1111/1471-0528.13456 [ DOI:10.1111/1471-0528.13456] [ PMID] 13. Oppegaard K S , Lieng M, Berg A, Istre O, Qvigstad E, Nesheim B-I. A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial. BJOG. 2010;117(1):53-61. Available from: DOI: 10.1111/j.1471-0528.2009.02435.x [ DOI:10.1111/j.1471-0528.2009.02435.x] [ PMID] [ ] 14. Justin J C,Adam J D, Leanne E B, Pollyanna H, Versha C,Yongzhong S,et al Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. ARTICLES| VOLUME 396, ISSUE 10253, P770-778, SEPTEMBER 12, 2020. Available from :DOI: [ DOI:10.1016/S0140-6736(20)31788-8] [ PMID] 15. Luther ER, Roux J, Popat R, Gardner A, Gray J, Soubiran E, et al. The effect of estrogen priming on induction of labor with prostaglandins. Am J Obstet Gynecol. 1980;137(3):351-7. Available from :DOI: 10.1016/0002-9378(80)90920-5 [ DOI:10.1016/0002-9378(80)90920-5] [ PMID] 16. Zuidema, LJ, Khan-Dawood F, Dawood M Y, Work B A. Hormones and cervical ripening: Dehydroepiandrosterone sulfate, estradiol, estriol, and progesterone. Am. J. Obstet. Gynecol, 1986;155(6): 1252-1254. Available from:DOI: 10.1016/0002-9378(86)90154-7 [ DOI:10.1016/0002-9378(86)90154-7] [ PMID] 17. Agah J, Zare F, Estiry M. A comparison study of outcome of induction of labor with vaginal misoprostol versus oxytocin: A randomized clinical trial. Life Sci, 2013; 10(8): 203-205 18. MacLENNAN AH, Green RC, Bryant-Greenwood GD, Greenwood FC, Seamark RF. Cervical ripening with combinations of vaginal prostaglandin F2-alpha estradiol, and relaxin. Obstet gynecol. 1981;58(5):601-4. 19. 19 .Magann E F, Perry K G, Dockery J R, Bass J D, Chauhan S P, Morrison J C. Cervical ripening before medical induction of labor: a comparison of prostaglandin E2, estradiol, and oxytocin. AJOG, 1995; 172(6): 1702-8. Available from: DOI: 10.1016/0002-9378(95)91401-3 [ DOI:10.1016/0002-9378(95)91401-3] [ PMID] 20. Ramos JG, Varayoud J, Kass L, Rodriguez H, Muñoz de Toro M, Montes GS, et al. Estrogen and progesterone modulation of eosinophilic infiltration of the rat uterine cervix. Steroids. 2000;65(7):409-14. Available from: DOI: 10.1016/s0039-128x(00)00098-2 [ DOI:10.1016/S0039-128X(00)00098-2] [ PMID] 21. Vaknin Z, Kurzweil Y, Sherman D. Foley catheter balloon vs locally applied prostaglandins for cervical ripening and labor induction: a systematic review and meta analysis. AJOG. 2010;203(5):418-29. Available from: DOI: 10.1016/j.ajog.2010.04.038 [ DOI:10.1016/j.ajog.2010.04.038] [ PMID] 22. Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst. Rev. 2010;6 (10):1-325. Available from :DOI: 10.1002/14651858.CD000941.pub2 [ DOI:10.1002/14651858.CD000941.pub2] 23. Rossi R, Warshak CR, Masters HR, Regan JK, Kritzer SA, Magner KP: Comparison of efficacy between prostaglandin and mechanical cervical ripening in the setting of small for gestational age neonates. AJOG. 2017;216(1):176-9. Available from: DOI: 10.1080/14767058.2018.1474873 [ DOI:10.1080/14767058.2018.1474873] [ PMID] 24. Larmon JE1, Magann EF, Dickerson GA, Morrison JC.Outpatient cervical ripening with prostaglandin E2 and estradiol. J Matern Fetal Neonatal Med. 2002;11(2):113-117. Available from: DOI: 10.1080/jmf.11.2.113.117 [ DOI:10.1080/jmf.11.2.113.117] [ PMID] 25. Dasgupta E, Singh G. Vaginal misoprostol vs vaginal misoprostol with estradiol for labor induction: a prospective double blind study. J Obstet Gynecol India. 2012; 62(1):47-51. Available from: DOI: 10.1007/s13224-012-0156-6 [ DOI:10.1007/s13224-012-0156-6] [ PMID] [ ] 26. Thomas J, Kelly AJ, Kavanagh J.Oestrogens alone or with amniotomy for cervical ripening or induction of labour.Cochrane Database Syst Rev. 2001;7(4):1-55. Available from: DOI: 10.1002/14651858.CD003393 [ DOI:10.1002/14651858.CD003393] |
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Ethics code: medsab.Rec.93.11 Clinical trials code: IRCTN..P36WWNQ
|
